IQV Iqvia Holdings Inc

Price (delayed)

$229.6

Market cap

$41.83B

P/E Ratio

30.94

Dividend/share

N/A

EPS

$7.42

Enterprise value

$54.13B

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development ...

Highlights
The price to earnings (P/E) is 61% lower than the 5-year quarterly average of 79.8 and 9% lower than the last 4 quarters average of 34.0
IQV's EPS is up by 31% year-on-year
Iqvia Holdings's debt has increased by 2.3% YoY

Key stats

What are the main financial stats of IQV
Market
Shares outstanding
182.2M
Market cap
$41.83B
Enterprise value
$54.13B
Valuations
Price to book (P/B)
6.57
Price to sales (P/S)
2.77
EV/EBIT
25.38
EV/EBITDA
16.56
EV/Sales
3.59
Earnings
Revenue
$15.07B
EBIT
$2.13B
EBITDA
$3.27B
Free cash flow
$1.62B
Per share
EPS
$7.42
Free cash flow per share
$8.93
Book value per share
$34.95
Revenue per share
$82.84
TBVPS
$40.31
Balance sheet
Total assets
$26.57B
Total liabilities
$20.23B
Debt
$13.74B
Equity
$6.34B
Working capital
-$797M
Liquidity
Debt to equity
2.17
Current ratio
0.88
Quick ratio
0.78
Net debt/EBITDA
3.76
Margins
EBITDA margin
21.7%
Gross margin
35%
Net margin
9%
Operating margin
13.4%
Efficiency
Return on assets
5.2%
Return on equity
22.6%
Return on invested capital
16.3%
Return on capital employed
10.6%
Return on sales
14.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IQV stock price

How has the Iqvia Holdings stock price performed over time
Intraday
1.11%
1 week
-0.68%
1 month
-4.67%
1 year
15.94%
YTD
-0.77%
QTD
-9.21%

Financial performance

How have Iqvia Holdings's revenue and profit performed over time
Revenue
$15.07B
Gross profit
$5.28B
Operating income
$2.01B
Net income
$1.36B
Gross margin
35%
Net margin
9%
Iqvia Holdings's net income has increased by 29% YoY
Iqvia Holdings's net margin has increased by 23% YoY
IQV's operating income is up by 13% year-on-year
Iqvia Holdings's operating margin has increased by 10% YoY

Growth

What is Iqvia Holdings's growth rate over time

Valuation

What is Iqvia Holdings stock price valuation
P/E
30.94
P/B
6.57
P/S
2.77
EV/EBIT
25.38
EV/EBITDA
16.56
EV/Sales
3.59
The price to earnings (P/E) is 61% lower than the 5-year quarterly average of 79.8 and 9% lower than the last 4 quarters average of 34.0
IQV's EPS is up by 31% year-on-year
The equity has grown by 7% YoY and by 3.8% from the previous quarter
The stock's price to book (P/B) is 4.8% less than its last 4 quarters average of 6.9 but 2.7% more than its 5-year quarterly average of 6.4
The stock's price to sales (P/S) is 4.5% less than its 5-year quarterly average of 2.9
IQV's revenue is up by 4% YoY

Efficiency

How efficient is Iqvia Holdings business performance
IQV's return on assets is up by 24% year-on-year
The ROE has increased by 20% YoY
The company's return on invested capital rose by 16% YoY
IQV's return on sales is up by 15% year-on-year

Dividends

What is IQV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IQV.

Financial health

How did Iqvia Holdings financials performed over time
The total assets is 31% greater than the total liabilities
The quick ratio has increased by 11% YoY and by 4% QoQ
Iqvia Holdings's current ratio has increased by 10% YoY and by 2.3% from the previous quarter
Iqvia Holdings's debt is 117% more than its equity
The equity has grown by 7% YoY and by 3.8% from the previous quarter
The debt to equity has decreased by 4.4% from the previous quarter and by 4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.